Article info
PDFLetters to JMG
Further evidence for heterozygote advantage of GJB2 deafness mutations: a link with cell survival
- Correspondence to: Professor David Kelsell Centre for Cutaneous Research, Institute of Cell and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary, University of London, Whitechapel, London, UK; david.kelsellcancer.org.uk
Citation
Further evidence for heterozygote advantage of GJB2 deafness mutations: a link with cell survival
Publication history
- Received December 16, 2003
- Accepted February 9, 2004
- First published July 2, 2004.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2004 Journal of Medical Genetics